Literature DB >> 20606728

Regulation of oxidative stress and inflammation by hepatic adiponectin receptor 2 in an animal model of nonalcoholic steatohepatitis.

Tokio Matsunami1, Yukita Sato, Satomi Ariga, Takuya Sato, Haruka Kashimura, Yuki Hasegawa, Masayoshi Yukawa.   

Abstract

The pathogenesis of nonalcoholic steatohepatitis (NASH) is not well understood; however, the progression of fatty liver to NASH has been linked to oxidative stress and lipid peroxidation in the liver, leading to inflammation. Although the adiponectin receptor 2 (AdipoR2) has been identified as a modulator of oxidative stress and inflammation in the liver, it remains unclear whether the receptor has hepatic antioxidant and anti-inflammatory effects in NASH. In this study, we used an animal model of NASH to examine hepatic AdipoR2. Obese fa/fa Zucker rats fed a high-fat and high-cholesterol (HFC) diet spontaneously developed fatty liver with inflammation and fibrosis, characteristic of NASH, after 4, 8, or 12 weeks of HFC diet consumption. AdipoR2 expression was significantly decreased, whereas the expression of genes related to NADPH oxidase complex were increased. As a result of the decrease in AdipoR2 expression, the mRNA expression of genes located downstream of AdipoR2, i.e., Cu-Zn superoxide dismutase (Cu-Zn SOD) and Mn-SOD, also decreased. Furthermore, the expression of genes related to inflammation was increased. Increased oxidative stress and inflammation by down-regulation of AdipoR2 may contribute to the progression of NASH. Thus, the AdipoR2 might be a crucially important regulator of hepatic oxidative stress and inflammation in NASH.

Entities:  

Keywords:  Nonalcoholic steatohepatitis; Zucker rats; adiponectin receptor 2; inflammation; oxidative stress

Mesh:

Substances:

Year:  2010        PMID: 20606728      PMCID: PMC2897102     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  28 in total

1.  A simple method for clinical assay of superoxide dismutase.

Authors:  Y Sun; L W Oberley; Y Li
Journal:  Clin Chem       Date:  1988-03       Impact factor: 8.327

2.  Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase.

Authors:  D E Paglia; W N Valentine
Journal:  J Lab Clin Med       Date:  1967-07

Review 3.  The evolving role of leptin and adiponectin in chronic liver diseases.

Authors:  Emmanuel Tsochatzis; George V Papatheodoridis; Athanasios J Archimandritis
Journal:  Am J Gastroenterol       Date:  2006-09-04       Impact factor: 10.864

4.  A high-fat diet leads to the progression of non-alcoholic fatty liver disease in obese rats.

Authors:  Michal Carmiel-Haggai; Arthur I Cederbaum; Natalia Nieto
Journal:  FASEB J       Date:  2004-11-02       Impact factor: 5.191

Review 5.  Adiponectin and adiponectin receptors.

Authors:  Takashi Kadowaki; Toshimasa Yamauchi
Journal:  Endocr Rev       Date:  2005-05       Impact factor: 19.871

6.  Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.

Authors:  E M Brunt; C G Janney; A M Di Bisceglie; B A Neuschwander-Tetri; B R Bacon
Journal:  Am J Gastroenterol       Date:  1999-09       Impact factor: 10.864

7.  Nitrosative stress predicts the presence and severity of nonalcoholic fatty liver at different stages of the development of insulin resistance and metabolic syndrome: possible role of vitamin A intake.

Authors:  Giovanni Musso; Roberto Gambino; Franco De Michieli; Giampaolo Biroli; Alberto Premoli; Gianfranco Pagano; Simona Bo; Marilena Durazzo; Maurizio Cassader
Journal:  Am J Clin Nutr       Date:  2007-09       Impact factor: 7.045

8.  Ascorbic acid concentrations in dimethylnitrosamine-induced hepatic fibrosis in rats.

Authors:  Joseph George
Journal:  Clin Chim Acta       Date:  2003-09       Impact factor: 3.786

9.  Nonalcoholic steatohepatitis: an expanded clinical entity.

Authors:  B R Bacon; M J Farahvash; C G Janney; B A Neuschwander-Tetri
Journal:  Gastroenterology       Date:  1994-10       Impact factor: 22.682

10.  Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase.

Authors:  T Yamauchi; J Kamon; Y Minokoshi; Y Ito; H Waki; S Uchida; S Yamashita; M Noda; S Kita; K Ueki; K Eto; Y Akanuma; P Froguel; F Foufelle; P Ferre; D Carling; S Kimura; R Nagai; B B Kahn; T Kadowaki
Journal:  Nat Med       Date:  2002-10-07       Impact factor: 53.440

View more
  17 in total

1.  Comparison of the effects of three different Baccaurea angulata whole fruit juice doses on plasma, aorta and liver MDA levels, antioxidant enzymes and total antioxidant capacity.

Authors:  Muhammad Ibrahim; Maryam Abimbola Mikail; Idris Adewale Ahmed; Norazlanshah Hazali; Mohammad Syaiful Bahari Abdul Rasad; Radiah Abdul Ghani; Ridzwan Hashim; Solachuddin Jahuari Arief; Muhammad Lokman Md Isa; Samsul Draman
Journal:  Eur J Nutr       Date:  2017-05-17       Impact factor: 5.614

2.  Adiponectin as an anti-fibrotic and anti-inflammatory adipokine in the liver.

Authors:  Pil-Hoon Park; Carlos Sanz-Garcia; Laura E Nagy
Journal:  Curr Pathobiol Rep       Date:  2015-09-30

3.  Pioglitazone abrogates cyclosporine-evoked hypertension via rectifying abnormalities in vascular endothelial function.

Authors:  Mahmoud M El-Mas; Hanan M El-Gowelli; Khaled S Abd-Elrahman; Evan I Saad; Abdel-Galil A Abdel-Galil; Abdel A Abdel-Rahman
Journal:  Biochem Pharmacol       Date:  2010-11-27       Impact factor: 5.858

4.  Ileal interposition surgery targets the hepatic TGF-β pathway, influencing gluconeogenesis and mitochondrial bioenergetics in the UCD-T2DM rat model of diabetes.

Authors:  Connie Hung; Eleonora Napoli; Catherine Ross-Inta; James Graham; Amanda L Flores-Torres; Kimber L Stanhope; Pascal Froment; Peter J Havel; Cecilia Giulivi
Journal:  FASEB J       Date:  2019-07-15       Impact factor: 5.191

Review 5.  NADPH Oxidases Connecting Fatty Liver Disease, Insulin Resistance and Type 2 Diabetes: Current Knowledge and Therapeutic Outlook.

Authors:  Alberto Nascè; Karim Gariani; François R Jornayvaz; Ildiko Szanto
Journal:  Antioxidants (Basel)       Date:  2022-06-09

6.  Mechanism of Huo-Xue-Qu-Yu Formula in Treating Nonalcoholic Hepatic Steatosis by Regulating Lipid Metabolism and Oxidative Stress in Rats.

Authors:  Bin Cheng; Ai-Zhen Zhou; Wen Ge; Xiao-Min Yao; Juan Wang
Journal:  Evid Based Complement Alternat Med       Date:  2021-04-29       Impact factor: 2.629

7.  Liver fibrogenesis in non-alcoholic steatohepatitis.

Authors:  Zhaolian Bian; Xiong Ma
Journal:  Front Physiol       Date:  2012-07-11       Impact factor: 4.566

8.  Pepsin Egg White Hydrolysate Ameliorates Obesity-Related Oxidative Stress, Inflammation and Steatosis in Zucker Fatty Rats.

Authors:  M Garcés-Rimón; C González; J A Uranga; V López-Miranda; R López-Fandiño; M Miguel
Journal:  PLoS One       Date:  2016-03-17       Impact factor: 3.240

9.  The effect of dietary fat intake on hepatic gene expression in LG/J AND SM/J mice.

Authors:  Charlyn G Partridge; Gloria L Fawcett; Bing Wang; Clay F Semenkovich; James M Cheverud
Journal:  BMC Genomics       Date:  2014-02-05       Impact factor: 3.969

10.  Herbal adaptogens combined with protein fractions from bovine colostrum and hen egg yolk reduce liver TNF-α expression and protein carbonylation in Western diet feeding in rats.

Authors:  C Brooks Mobley; Ryan G Toedebusch; Christopher M Lockwood; Alexander J Heese; Conan Zhu; Anna E Krieger; Clayton L Cruthirds; John C Hofheins; Joseph M Company; Charles E Wiedmeyer; Dae Y Kim; Frank W Booth; Michael D Roberts
Journal:  Nutr Metab (Lond)       Date:  2014-04-23       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.